The 29th Annual Meeting of Japan Society of Gene and Cell Therapy

Presentation information

Print

Oral Session

[O3] Oral Session 3"Cancer 1"

Mon. Sep 11, 2023 3:25 PM - 4:35 PM Room 3 (1008, 10Ｆ, OICC)

Chairs:Hideki Kasuya（Nagoya University, Cancer Immune therapy center）,Shuji Kubo（Laboratory of Molecular and Genetic Therapeutics, Institute for Advanced Medical Sciences, Hyogo Medical University）

[O3-6] Augmentation of anti-tumor effects of receptor-retargeted oncolytic HSV (RR-oHSV) through introduction of syn mutations

○Takuma Suzuki1, Hideaki Tahara2, Hiroaki Uchida1 (1.Tokyo University of Pharmacy and Life Sciences, 2.Osaka International Cancer Institute)

Abstract password authentication.
The password was sent to all registrants in email.

Password